Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04305054 |
|---|---|
| Brief Title: | Substudy 02B: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With First Line (1L) Advanced Melanoma (MK-3475-02B/KEYMAKER-U02) |
| First Submitted : | March 9, 2020 |
| First Submitted that Met QC Criteria : | March 9, 2020 |
| First Posted : | March 12, 2020 |
| Last Update Submitted that Met QC Criteria : | March 15, 2023 |
| Last Update Posted : | March 16, 2023 |